| [1] |
Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites in cirrhosis(2023 version)[J]. Chin J Hepatol, 2023, 31( 8): 813- 826. DOI: 10.3760/cma.j.cn501113-20230719-00011. |
| [2] |
BAJAJ JS, KHORUTS A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis[J]. J Hepatol, 2020, 72( 5): 1003- 1027. DOI: 10.1016/j.jhep.2020.01.017. |
| [3] |
LU HF, ZHU XF, WU LY, et al. Alterations in the intestinal microbiome and metabolic profile of patients with cirrhosis supplemented with lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: A randomized placebo-controlled trial[J]. Front Microbiol, 2023, 14: 1169811. DOI: 10.3389/fmicb.2023.1169811. |
| [4] |
BAJAJ JS, FAGAN A, GAVIS EA, et al. Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis[J]. Gastroenterology, 2019, 156( 6): 1921- 1923.e3. DOI: 10.1053/j.gastro.2019.01.033. |
| [5] |
LIU Y, LU M, HONG W, et al. Improvement effect of curcumin combined with fecal bacteria transplantation on mice with ulcerative colities induced by DSS[J]. J Jilin Univ Med Ed, 2024, 50( 1): 136- 142. DOI: 10.13481/j.1671-587X.20240117. |
| [6] |
LUO B, LI Q, YI F, et al. Predictive value of a novel inflammation index combined with serum albumin for the prognosis of patients with cirrhotic ascites[J]. Trauma Critical Care Med, 2025, 13( 6): 447- 450. DOI: 10.16048/j.issn.2095-5561.2025.06.09. |
| [7] |
Viral Hepatitis Group of Professional Committee of Liver Disease(combined traditional Chinese and western medicine) of Chinese Research Hospital Association, Zhejiang Provincial Key Laboratory for Accurate Diagnosis and Treatment of Chronic Liver Diseases. Guidelines for fecal microbiota transplantation therapy in patients with liver cirrhosis[J]. J Clin Hepatol, 2025, 41( 3): 424- 431. DOI: 10.12449/JCH250306. 中国研究型医院学会肝病(中西医结合)专业委员会病毒性肝炎学组, 浙江省慢性肝病重症化精准诊治与规模转化重点实验室. 肝硬化患者粪菌移植治疗指南[J]. 临床肝胆病杂志, 2025, 41( 3): 424- 431. DOI: 10.12449/JCH250306. |
| [8] |
SHARMA A, ROY A, PREMKUMAR M, et al. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: An open-label clinical trial[J]. Hepatol Int, 2022, 16( 2): 433- 446. DOI: 10.1007/s12072-022-10312-z. |
| [9] |
PHILIPS CA, AHAMED R, RAJESH S, et al. Clinical outcomes and gut microbiota analysis of severe alcohol-associated hepatitis patients undergoing healthy donor fecal transplant or pentoxifylline therapy: Single-center experience from Kerala[J]. Gastroenterol Rep, 2022, 10: goac074. DOI: 10.1093/gastro/goac074. |
| [10] |
QIN N, YANG FL, LI A, et al. Alterations of the human gut microbiome in liver cirrhosis[J]. Nature, 2014, 513( 7516): 59- 64. DOI: 10.1038/nature13568. |
| [11] |
JIANG HL, PENG Y, ZHANG W, et al. Gut microbiome-targeted therapies in liver cirrhosis: A protocol for systematic review and meta-analysis[J]. Syst Rev, 2022, 11( 1): 181. DOI: 10.1186/s13643-022-02059-3. |
| [12] |
ZHAO Y, GUO Y, HUANG N, et al. Gut microbiota of patients with cirrhosis promotes cirrhosis development by injuring intestinal mucosal barrier in mice[J]. Chin J Exp Surg, 2021, 38( 8): 1567- 1570. DOI: 10.3760/cma.j.cn421213-20201210-00905. |
| [13] |
HU TT, WU QQ, YAO Q, et al. Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases[J]. Ageing Res Rev, 2022, 81: 101706. DOI: 10.1016/j.arr.2022.101706. |
| [14] |
ZHANG ZY, LV TT, WANG X, et al. Role of the microbiota-gut-heart axis between bile acids and cardiovascular disease[J]. Biomed Pharmacother, 2024, 174: 116567. DOI: 10.1016/j.biopha.2024.116567. |
| [15] |
LUO M, DU YW, LIU XC, et al. Fecal microbiota transplantation alleviates cirrhotic portal hypertension in rats via butyrate-mediated HDAC3 inhibition and PI3K/Akt/ENOS signaling regulation[J]. Eur J Pharmacol, 2025, 1002: 177781. DOI: 10.1016/j.ejphar.2025.177781. |
| [16] |
VOIOSU A, WIESE S, VOIOSU T, et al. Bile acids and cardiovascular function in cirrhosis[J]. Liver Int, 2017, 37( 10): 1420- 1430. DOI: 10.1111/liv.13394. |
| [17] |
XU HK, WANG CF, ZHANG Y, et al. Role of fecal microbiota transplantation in chronic liver diseases[J]. J Clin Hepatol, 2023, 39( 9): 2237- 2243. DOI: 10.3969/j.issn.1001-5256.2023.09.031. |
| [18] |
ARAB JP, MARTIN-MATEOS RM, SHAH VH. Gut–liver axis, cirrhosis and portal hypertension: The chicken and the egg[J]. Hepatol Int, 2018, 12( 1): 24- 33. DOI: 10.1007/s12072-017-9798-x. |
| [19] |
LIU T, SONG WQ, ZHUANG JY, et al. Effect of high-salt-fat diet and fecal microbiota transplantation in gut and gut microbiota[J]. Chin J Inflamm, 2019, 3( 3): 227- 232. DOI: 10.3760/cma.j.issn.2096-367X.2019.03.011 |
| [20] |
de FILIPPIS F, PELLEGRINI N, VANNINI L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome[J]. Gut, 2016, 65( 11): 1812- 1821. DOI: 10.1136/gutjnl-2015-309957. |
DownLoad: